Welcome to PakSearch.com Pakistan's Premier Business Information
Service


For business information, annual reports, laws, ordinances, regulations and articles.




Google
 
Web Paksearch.com
CHANAMID PAKISTAN LTD
ANNUAL REPORT 1997
CONTENTS
NOTICE OF ANNUAL GENERAL MEETING
COMPANY NEWS
REPORT OF THE DIRECTORS
GRAPHS
AUDITORS' REPORT TO THE MEMBERS
BALANCE SHEET
PROFIT AND LOSS ACCOUNT
CASH FLOW STATEMENT
NOTES TO THE ACCOUNTS
10 YEARS HISTORY
PATTERN OF SHAREHOLDING
Notice of Annual General Meeting
NOTICE is hereby given that the Forty Ninth Annual General Meeting of Cyanamid (Pakistan)
Limited will be held on Friday, May 29, 1998 at 10.30 a.m. at the Registered Office of the Company,
S-33, Hawkesbay Road, S.I.T.E., Karachi to transact the following business:
ORDINARY BUSINESS:
1. To confirm the minutes of the Forty Eighth Annual General Meeting of the Company held on May 30,
1997.
2. To receive, consider and adopt the Audited Accounts together with the Directors' and Auditors' Reports
for the year ended November 30, 1997.
3. To approve Dividend.
4. To appoint Auditors for the year ending November -30, 1998, at a fee to be Fixed by the Board of
Directors.
NOTES:
1. The Share Transfer Books of the Company will remain closed from Friday, May 22,1998 to Friday,
May 29, 1998 (both days inclusive).
2. A member entitled to attend and vote at the Annual General Meeting may appoint a proxy to attend and
vote instead of him/her. A Proxy need not be a member of the Company. Proxies in order to be valid,
must be received at the Registered Office of the Company not later than 48 hours before the meeting.
3. Members are requested to promptly communicate to the Company Registrar Messrs T.H.K.
Associates (Pvt) Limited any change in their address.
Company News
BOARD OF DIRECTORS
Farooq Hadi Chairman & Managing Director (C.E.O.)
Akber Saifi
S. Masood Abbas Jaffery
J. R. Stafford (Alternate: S. Anwarul Haque)
Marco A. Fonseca (Alternate: Khwaja Bakhtiar Ahmed)
Bernard Poussot (Alternate: M. Mustafa Khan)
Razi-ur-Rahman Khan
COMPANY SECRETARY
Khwaja Bakhtiar Ahmed
BANKERS
ABN-Amro Bank
American Express Bank Limited
ANZ Grindlays Bank
Bank of America NT&SA
Habib Bank Limited
Muslim Commercial Bank Limited
Mashreq Bank
Standard Chartered Bank
AUDITORS
A.F. Ferguson & Company
LEGAL ADVISORS
Orr. Digham & Company
SHARE REGISTRAR
T.H.K. Associates (Pvt) Ltd.
Ground Floor,
Shaikh Sultan Trust Building No.2,
Beaumont Road,
Karachi.
REGISTERED OFFICE
S-33, Hawkesbay Road, S.I.T.E.,
G.P.O. Box No. 167, Karachi.
Telephone: 2564306-10 & 111-777-333
Fax: 92-21-2564428
Report of the directors
Your Directors take pleasure in presenting their Report and Accounts for the year ended November 30,
1997.
OPERATIONS
While sales for the year increased by 7.4%, Profit Before Tax showed a substantial decline of 52.1%. The
decline in profits was primarily due to such factors as:
· Three major devaluations of the Rupee during the period September 1996 to October 1997.
· Imposition of Import Duty on pharmaceutical raw and packaging materials.
· Continued high inflation and a totally inadequate increase in prices.
The Directors feel that the results would have been much better if these adverse factors had not affected
the operations. In this situation, such matters as strict control of expenses and improved efficiencies
continue to be the focus of Management's attention.
Your Company introduced three new products during the last quarter of the year. TAZOCIN (Tazobactam/
Piperacillin) - a highly effective antibiotic for first line treatment of hospital infections, EFEXOR
(Venlafaxine), the world's first SNRI, a new anti-depressant and MONOTRATE (Isosorbide Mononitrate), a
cardiovascular product for Angina Pectoris. As the initial results for all three products show promise, we
are hopeful that during the coming years these products will contribute substantially to the sales and profit
of your Company.
FINANCIAL RESULTS
Operating results for the year ended November 30, 1997 together with Directors' recommendations of
appropriations are provided as follows:
(Rupees '000)
Profit After Tax 49,734
Unappropriated Profit brought forward 2,004
----------
51,738
Appropriations:
Dividend 14,216
Transfer to General Reserve 36,000 50,216
Unappropriated Profit carried forward ---------- ----------
1,522
==========
DIVIDEND
The Directors recommend a Dividend of 10% for the year ended November 30, 1997.
DIRECTORS
During the year Mr. Aijaz K. Khan retired as Chairman of the Board and Mr. Farooq Hadi replaced him in
that position. Mr. Aijaz Khan was replaced on the Board by Mr. S. Masood Abbas Jaffery. The Board of
Directors wish to place on record their appreciation of the services rendered by the former Chairman and
welcome the new Director.
PROSPECTS
While the investment policies of the present government are amongst the most attractive anywhere in
Asia, the implementation of these policies as well as concerns about the consistency of these policies
remain a major hurdle to further investment.
The pharmaceutical industry which has long suffered due to strict price controls continue to view the future
as somewhat bleak. The present government which had introduced a transparent pricing formula for
controlled drugs while at the same time decontrolling others has also not moved on this front. No price
increases have been forthcoming since November 1996. This together with major devaluation as well as
continued high inflation, seriously affect the operations of this Industry and of your Company.
While your Company through several Industry for a has been making extensive efforts to make the
government realize that the situation is serious and the credibility of the government's own policies is at
stake, so far the efforts have not brought about any change in the situation. However, with the
government's intentions of seeking foreign investment as well as liberalizing the economy, we continue to
hope that some sense will eventually prevail.
SUBSEQUENT EVENTS
No material changes or commitment affecting financial position of the Company have taken place
between the end of financial year and the date of this report.
AUDITORS
The present Auditors, A.F. Ferguson & Company retire and being eligible offer themselves for
reappointment.
EMPLOYEES
The Directors are pleased to acknowledge that relations between management and workers remained
cordial throughout the year.
The Directors wish to thank all employees for their hard work and devotion to duty and expect them to
continue in the same spirit in future.
PARENT COMPANIES
American Home Products Corporation, incorporated in the State of Delaware, U.S.A. with its principal
place of business located in Madison, New Jersey, U.S.A. holds 576,470 (40.55%) shares of the Company;
and American Cyanamid Company, incorporated in the State of Maine, U.S.A. with its principal place of
business located in Madison, New Jersey, U.S.A. (100% owned company of American Home Products
Corporation) holds 448,560 (31.55%) shares of the Company; thus, the total holding of both the
Companies is 72.10%.
PATTERN OF SHAREHOLDING
A statement of Pattern of Shareholding of the Company as at November 30, 1997 is shown on Page 33.
Earning per share for the year is Rs. 34.98.
Auditors' report to the members
We have audited the annexed balance sheet of Cyanamid (Pakistan) Limited as at November 30, 1997
and the related profit and loss account and cash flow statement, together with the notes forming part
thereof, for the year then ended and we state that we have obtained all the information and explanations
which to the best of our knowledge and belief were necessary for the purpose of our audit and, after due
verification thereof, we report that:
(a) in our opinion, proper books of account have been kept by the Company as required by the
Companies Ordinance, 1984;
(b) in our opinion:
(i) the balance sheet and profit and loss account together with the notes thereon have been
drawn up in conformity with the Companies Ordinance, 1984 and are in agreement with
the books of account and are further in accordance with accounting policies consistently
applied;
(ii) the expenditure incurred during the year was for the purpose of the Company's
business; and
(iii) the business conducted, investments made and the expenditure incurred during the year
were in accordance with the objects of the Company;
(c) in our opinion and to the best of our information and according to the explanations given to us, the
balance sheet and profit and loss account together with the notes forming part thereof, give the
information required by the Companies Ordinance, 1984 in the manner so required and
respectively give a true and fair view of the state of the Company's affairs as at November 30,
1997 and of the profit and cash flows for the year then ended; and
(d) in our opinion Zakat deductible at source under the Zakat and Ushr Ordinance, 1980 was
deducted by the Company and deposited in the Central Zakat Fund established under Section,
of that Ordinance.
A.F. FERGUSON
Karachi: April 21, 1998 CHARTERED ACCOUNTANTS
BALANCE SHEET AS AT NOVEMBER 30, 1997
Note 1997 1996
     (Rupees '000)
Fixed Assets - Tangible 3 170,611 171,588
Capital Work-in-Progress 4 14,437 3,099
Goodwill 5 10,051 11,726
Deferred Cost 6 - 5,761
Long term Loans, deposits and prepayments 7 12,715 8,347
CURRENT ASSETS ---------- ----------
Stores, spares and loose tools 8 38,380 39,053
Stock-in-trade 9 504,326 538,562
Trade debts 10 629,516 358,156
Loans, advances, deposits, prepayments and
other receivables 11 81,295 72,211
Taxation 12 68,343 -
Cash and bank balances 13 1,255 15,261
---------- ----------
####### #######
LESS: CURRENT LIABILITIES
Current maturity of liability against assets
subject to finance leases 6,600 4,075
Short term loans - unsecured 14 419,070 40,361
Running Finance under mark-up arrangements 15 78,435 172,593
Creditors, accrued and other Liabilities 16 452,967 445,105
Dividends 17 14,584 29,275
Taxation - 5,749
---------- ----------
971,656 697,158
---------- ----------
NET CURRENT ASSETS 351,459 326,085
---------- ----------
NET ASSETS 559,273 526,606
========== ==========
FINANCED BY:
Share capital 18 142,161 142,161
Reserves 19 382,147 346,147
Unappropriated profit 1,522 2,004
---------- ----------
Shareholders' equity 525,830 490,312
Liability against assets subject to finance leases 20 7,849 8,363
Deferred Liabilities 21 25,594 27,931
CONTINGENCIES AND COMMITMENTS 22 ---------- ----------
559,273 526,606
========== ==========
The annexed notes form an integral part of these accounts.
PROFIT AND LOSS ACCOUNT FOR THE 
YEAR ENDED NOVEMBER 30, 1997
Note 1997 1996
     (Rupees '000)
Sales - Net 23 ####### #######
Cost of goods sold 24 ####### #######
---------- ----------
Gross profit 513,170 519,952
---------- ----------
Administrative and general expenses 25 128,149 106,334
Selling and distribution expenses 26 226,056 188,493
---------- ----------
354,205 294,827
---------- ----------
158,965 225,125
Other income 27 4,920 5,868
---------- ----------
163,885 230,993
---------- ----------
Financial charges 28 73,907 50,891
Amortization of goodwill 1,675 1,675
Amortization of deferred cost 5,761 7,682
Research and development contribution 874 1,481
Workers' profits participation fund 4,178 8,548
Workers' welfare fund 2,144 3,403
---------- ----------
88,539 73,680
---------- ----------
Profit before taxation 75,346 157,313
Taxation ---------- ----------
Current year 30,928 55,981
Prior year's - (4,479)
Deferred (5,316) (4,426)
---------- ----------
25,612 47,076
---------- ----------
Profit after taxation 49,734 110,237
Unappropriated profit brought forward 2,004 714
---------- ----------
Profit available for appropriation 51,738 110,951
Dividend ---------- ----------
Interim 29 - 14,731
Proposed final Rs10 (1996: Rs 10 per share) 14,216 14,216
---------- ----------
14,216 28,947
Transfer to general reserve 36,000 80,000
---------- ----------
Unappropriated profit carried forward 1,522 2,004
========== ==========
The annexed notes form an integral part of these accounts.
CASH FLOW STATEMENT FOR THE YEAR ENDED NOVEMBER 30, 1997
Note 1997 1996
     (Rupees '000)
CASH FLOW FROM OPERATING ACTIVITIES
Cash (used in)/generated from operations 33 (74,118) 79,642
---------- ----------
Interest and mark-up paid (40,712) (25,069)
Lease finance charges paid (2,475) (2,731)
Income tax paid (111,343) (89,973)
Payment of gratuity (3,240) (2,684)
Interest received - 1,293
(Increase)/Decrease in long-term loans, deposits
and prepayments (4,145) 1,530
---------- ----------
(161,915) (117,634)
---------- ----------
Net cash outflow from operating activities (236,033) (37,992)
CASH FLOW FROM INVESTING ACTIVITIES
Fixed capital expenditure (38,576) (30,574)
Sale proceed of fixed assets 3,372 1,316
---------- ----------
Net cash outflow from investing activities (35,204) (29,258)
CASH FLOW FROM FINANCING ACTIVITIES ---------- ----------
Dividend paid (28,907) (27,181)
Increase/(Decrease) in short term loans 378,709 (25,319)
Increase/(Decrease) in liability against
assets subject to finance leases 2,011 (4,923)
Other (424) 303
---------- ----------
Net cash inflow/(outflow) from financing activities 351,389 (57,120)
---------- ----------
Net increase/(decrease)in cash and cash equivalents 80,152 124,370)
Cash and cash equivalents at the beginning of the year (157,332) (32,962)
---------- ----------
Cash and cash equivalents at the end of the year 34 (77,180) (157,332)
========== ==========
The annexed notes form an integral part of these accounts.
NOTES TO THE ACCOUNTS FOR THE YEAR ENDED NOVEMBER 30, 1997
1. STATUS AND NATURE OF BUSINESS
Cyanamid (Pakistan) Limited is a public limited company quoted on the Karachi and Lahore Stock
Exchanges. The current business activities of the company consist of the manufacture and marketing
of research based ethical specialities and other pharmaceutical and agro-chemical products.
2. SIGNIFICANT ACCOUNTING POLICIES
2.1 Accounting convention
These accounts have been prepared under the historical cost convention
2.2 Staff retirement benefits
The Company operates
(a) An approved funded gratuity scheme for its all permanent employees except that separate funded
and unfunded schemes are in operation for employees of former Wyeth Laboratories (Pakistan)
Limited. Contributions are made annually to the fund on the basis of actuarial recommendations
at the rate of 8.33% of basic salary and additionally a book provision of Rs.18.751 million is also
made as per actuarial recommendation. An actuarial valuation is performed once in every three
years and the most recent actuarial valuation of the scheme was carried out at November 30,
1996, which reflected the fair value of the fund's assets and the liabilities at Rs. 15.60 million and
Rs.34.36 million respectively. The actuarial valuation was carried out using Entry Age Normal
Method. Main valuation assumptions used for actuarial valuation were as under:
· Expected rate of increase in salaries 14% per annum.
· Expected rate of return on investment 14% per annum.
(b) An approved funded gratuity scheme for all employees of former Wyeth Laboratories (Pakistan)
Limited except for certain unionised staff. Annual contributions are made to the gratuity fund at
the rate of 5.55 per cent per annum of basic salaries. Actuarial recommendations for 1997
contribution rates are 5.67 and 4.32 per cent of annual basic salaries for current cost and past
service liability respectively. The actuarial valuation of the scheme is carried out every year and
the latest valuation was carried out as at November 30, 1996. The fair value of the Fund's assets
and the liabilities for past services at the latest valuation date was for Rs.20.54 million and
Rs.46.38 million respectively. The future contribution rate of this plan includes allowances for
deficit and surplus. Attained Age Method, using the following assumptions, is used for valuation
of this plan:
· Expected rate of increase in salary level 12 per cent per annum.
· Expected rate of return on investment 12 per cent per annum.
An unfunded gratuity scheme for certain unionized staff to provide for gratuity under the West
Pakistan Industrial and Commercial Employment (Standing Order) 1968, for the period during
which they were not covered by the provident fund schemes, the provisions for which are charged
to income currently.
(c) An approved funded pension scheme for the management staff of former Wyeth Laboratories
(Pakistan) Limited. Annual contributions are made to the pension fund on the basis of actuarial
recommendations. The actuarial valuation of the scheme is carried out every year. The latest
valuation was carried out on January 1, 1996. The valuation for the year ended November 30,